Vaughan & Co Securities’s Sanofi SNY Stock Holding History

Vaughan & Co Securities’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-33	Closed	-$1.66K	–	169
2019 Q4	$1.66K	Buy	+33	New	+$1.55K	﹤0.01%	163

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vaughan & Co Securities's SNY Position: Q1 2020 in Review

Vaughan & Co Securities sold out of Sanofi (SNY) in Q1 2020, closing a stake of 33 shares — an estimated $1.66K sold.

Vaughan & Co Securities first reported a position in SNY in Q4 2019 and held it in 1 quarter. The position peaked at $1.66K in Q4 2019. 547 funds tracked by Wall St. Rank hold SNY as of Q1 2020.

Vaughan & Co Securities reported no remaining Sanofi position as of Q1 2020 after selling out during the quarter.
Vaughan & Co Securities sold 33 Sanofi shares in Q1 2020, an estimated $1.66K.
Vaughan & Co Securities first reported a position in Sanofi in Q4 2019 and held it in 1 quarter.
Vaughan & Co Securities's Sanofi position peaked at $1.66K in Q4 2019.
547 funds tracked by Wall St. Rank held Sanofi as of Q1 2020.

Based on Vaughan & Co Securities's 13F filing for Q1 2020, filed 28 May 2020.